Evidence map›Paper›PMID 35190250›Full record

ArticleCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique2022

[Impact of a positive coronavirus diagnostic test on the radiotherapy patient journey at Gustave-Roussy institute].

V Chiesa, R Sun, G Brusadin, M-S Bour, S Corbin

Open access · greenAbstract read
In one paragraph

Article in Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

V ChiesaDépartement d'oncologie radiothérapie-2, Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France. Electronic address: virignie.chiesa@gustaveroussy.fr.
R SunDépartement d'oncologie radiothérapie-2, Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France.
G BrusadinDépartement d'oncologie radiothérapie-2, Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France.
M-S BourDépartement d'oncologie radiothérapie-2, Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France.
S CorbinDépartement d'oncologie radiothérapie-2, Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France.
Institut Gustave Roussy · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe coronavirus disease 2019 (COVID-19) epidemic continues to spread exponentially around the world. Cancer patients have a higher risk of commorbidity than the rest of the population. Radiotherapy departments are actively involved in the management of these patients, whether they have COVID or not, and it is recognized that the time taken to take charge and the continuity of treatment have a prognostic impact. The main objective was to assess the impact of the coronavirus on the treatment times of patients undergoing radiotherapy. MATERIAL AND

methodsThis retrospective study was conducted in the radiotherapy department of Gustave-Roussy institute (France) during the period from March 3, 2020 to January 12, 2021. Organizational changes, patient care times between the day of the scan and the last radiotherapy session as well as the time taken to take charge of patients between the first session and the last radiotherapy session has been studied.

resultsA total of 1183 patients were included, among which 60 had COVID-19. Patients were divided into four categories. Treatment times of patients who did not have COVID-19 and those of patients who did were not statistically significantly different.

conclusionThe organization of the radiotherapy department at the Gustave-Roussy institute is based on several points: carrying out preventive screening tests, protecting staff and patients and reorganizing the patient circuit. Thanks to the performance of diagnostic tests and the implementation of a specific workflow for patients with COVID, we ensure the continuity of patient treatment in complete safety without impacting treatment times.

Indexed as

COVID-19NeoplasmsRadiation OncologyDiagnostic Tests, RoutineHumansRetrospective StudiesCoronavirusCoronavirus diseaseCOVID-19Parcours patientPCRRadiothérapieRadiotherapyWorkflow

Identifiers

PMID35190250
PMCPMC8784571
OpenAlexW4206986396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.